Capital Analysts, LLC Merck & Co., Inc. Transaction History

Capital Analysts, LLC

$2.45 Billion
Q3 2024

A detailed history of Capital Analysts, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Capital Analysts, LLC holds 60,731 shares of MRK stock, worth $5.85 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

60,731

Previous 60,249 0.8%

Holding current value

$5.85 Million

Previous $7.46 Million 7.55%

% of portfolio

0.28%

Previous 0.33%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$111.15 - $128.97 $53,574 - $62,163	482 Added 0.8%	60,731 $6.9 Million
Q2 2024 Aug 14, 2024	SELL	$123.8 - $132.96 $43,825 - $47,067	-354 Reduced 0.58%	60,249 $7.46 Million
Q1 2024 May 14, 2024	SELL	$113.24 - $131.95 $316,392 - $368,668	-2,794 Reduced 4.41%	60,603 $8 Million
Q4 2023 Jan 30, 2024	SELL	$100.18 - $109.02 $89,160 - $97,027	-890 Reduced 1.38%	63,397 $6.91 Million
Q3 2023 Nov 13, 2023	SELL	$102.95 - $114.33 $9,677 - $10,747	-94 Reduced 0.15%	64,287 $6.62 Million
Q2 2023 Aug 11, 2023	SELL	$108.61 - $118.38 $354,068 - $385,918	-3,260 Reduced 4.82%	64,381 $7.43 Million
Q1 2023 May 05, 2023	BUY	$102.94 - $114.86 $20,073 - $22,397	195 Added 0.29%	67,641 $7.2 Million
Q4 2022 Feb 08, 2023	BUY	$87.44 - $112.11 $28,243 - $36,211	323 Added 0.48%	67,446 $7.48 Million
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $173,540 - $194,952	2,053 Added 3.16%	67,123 $5.78 Million
Q2 2022 Aug 12, 2022	BUY	$83.49 - $94.64 $172,907 - $195,999	2,071 Added 3.29%	65,070 $5.93 Million
Q1 2022 May 12, 2022	BUY	$73.51 - $82.4 $83,580 - $93,688	1,137 Added 1.84%	62,999 $5.17 Million
Q4 2021 Feb 10, 2022	BUY	$72.28 - $90.54 $41,127 - $51,517	569 Added 0.93%	61,862 $4.74 Million
Q3 2021 Nov 04, 2021	BUY	$71.68 - $78.83 $16,988 - $18,682	237 Added 0.39%	61,293 $4.6 Million
Q2 2021 Nov 15, 2021	SELL	$70.31 - $77.77 $243,764 - $269,628	-3,467 Reduced 5.37%	61,056 $4.75 Million
Q2 2021 Aug 05, 2021	BUY	$70.31 - $77.77 $412,016 - $455,732	5,860 Added 9.99%	64,523 $5.02 Million
Q1 2021 May 17, 2021	BUY	$68.86 - $81.11 $149,770 - $176,414	2,175 Added 3.85%	58,663 $4.52 Million
Q4 2020 Feb 16, 2021	SELL	$71.77 - $79.65 $52,679 - $58,463	-734 Reduced 1.28%	56,488 $4.62 Million
Q3 2020 Nov 12, 2020	SELL	$73.18 - $82.95 $125,210 - $141,927	-1,711 Reduced 2.9%	57,222 $4.75 Million
Q2 2020 Aug 07, 2020	SELL	$70.42 - $80.13 $45,420 - $51,683	-645 Reduced 1.08%	58,933 $4.56 Million
Q1 2020 May 08, 2020	SELL	$63.36 - $87.82 $20,148 - $27,926	-318 Reduced 0.53%	59,578 $4.58 Million
Q4 2019 Feb 12, 2020	SELL	$77.58 - $87.54 $156,556 - $176,655	-2,018 Reduced 3.26%	59,896 $5.45 Million
Q3 2019 Nov 12, 2019	BUY	$76.08 - $82.93 $172,853 - $188,416	2,272 Added 3.81%	61,914 $5.21 Million
Q2 2019 Aug 13, 2019	SELL	$69.84 - $81.59 $163,285 - $190,757	-2,338 Reduced 3.77%	59,642 $5 Million
Q1 2019 May 13, 2019	SELL	$69.58 - $79.36 $32,563 - $37,140	-468 Reduced 0.75%	61,980 $5.15 Million
Q4 2018 Feb 13, 2019	SELL	$65.24 - $75.71 $95,054 - $110,309	-1,457 Reduced 2.28%	62,448 $4.77 Million
Q3 2018 Nov 07, 2018	SELL	$57.69 - $67.84 $33,517 - $39,415	-581 Reduced 0.9%	63,905 $0
Q2 2018 Aug 03, 2018	BUY	$50.83 - $59.72 $92,764 - $108,989	1,825 Added 2.91%	64,486 $0
Q1 2018 May 14, 2018	BUY	$50.96 - $59.23 $183,710 - $213,524	3,605 Added 6.1%	62,661 $3.41 Million
Q4 2017 Feb 14, 2018	BUY	$51.62 - $61.64 $3.02 Million - $3.61 Million	58,579 Added 12280.71%	59,056 $3.32 Million
Q4 2017 Feb 12, 2018	SELL	$51.62 - $61.64 $3.06 Million - $3.65 Million	-59,277 Reduced 99.2%	477 $65,000
Q3 2017 Nov 06, 2017	BUY	$58.67 - $63.13 $3.51 Million - $3.77 Million	59,754	59,754 $3.83 Million

Others Institutions Holding MRK

# of Institutions

3,821

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $244B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Analysts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Analysts, LLC with notifications on news.

Account

Capital Analysts, LLC Merck & Co., Inc. Transaction History